Who is sponsoring NCT02843828?

NCT02843828 is sponsored by Samsung Medical Center.

What drugs are being tested in NCT02843828?

Interventions in NCT02843828: gait rehabilitation with Samsung Hip Assist v1, gait rehabilitation without Samsung Hip Assist v1.

What condition does NCT02843828 study?

NCT02843828 studies Stroke, Healthy.

Is NCT02843828 still recruiting?

NCT02843828 is currently completed. Last updated 10 April 2019.

Last reviewed 2019-04-10 · How we verify

NCT02843828

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gait Pattern Analysis and Feasibility of Gait Training With a Walking Assist Robot in Stroke Patients and Elderly Adults

Completed NA Last updated 10 April 2019

What this trial tests

NA trial testing gait rehabilitation with Samsung Hip Assist v1 in Stroke in 56 participants. Completed in 1 September 2017.

Timeline

2 January 2016

Primary endpoint
30 August 2017

1 September 2017

Quick facts

Lead sponsor	Samsung Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	56
Start date	2 January 2016
Primary completion	30 August 2017
Estimated completion	1 September 2017
Sites	1 location across South Korea

Drugs / interventions tested

gait rehabilitation with Samsung Hip Assist v1
gait rehabilitation without Samsung Hip Assist v1

Conditions studied

Stroke — all drugs for Stroke →
Healthy — all drugs for Healthy →

Sponsor

Samsung Medical Center

Who can join

Adults 50 to 84, any sex, with Stroke or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to investigate the effects of the new wearable hip assist robot developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) to gait rehabilitation in elderly adults and stroke patients.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Electromechanical-assisted training for walking after stroke.
Mehrholz J, Thomas S, Kugler J, Pohl M, et al · · 2020 · cited 146× · PMID 33091160 · DOI 10.1002/14651858.cd006185.pub5
Electromechanical-assisted training for walking after stroke.
Mehrholz J, Thomas S, Werner C, Kugler J, et al · · 2017 · cited 117× · PMID 28488268 · DOI 10.1002/14651858.cd006185.pub4
Training for Walking Efficiency With a Wearable Hip-Assist Robot in Patients With Stroke: A Pilot Randomized Controlled Trial.
Lee HJ, Lee SH, Seo K, Lee M, et al · · 2019 · cited 62× · PMID 31623545 · DOI 10.1161/strokeaha.119.025950
Gait performance and foot pressure distribution during wearable robot-assisted gait in elderly adults.
Lee SH, Lee HJ, Chang WH, Choi BO, et al · · 2017 · cited 43× · PMID 29183379 · DOI 10.1186/s12984-017-0333-z
Gait Training with Wearable Hip-assist Robot Reduce Trunk and Leg Muscle Efforts and Metabolic Energy Consumption in Community Dwelling Elderly Adults: A Randomized Controlled Trial
Lee H, Lee SH, Chang WH, Seo K, et al · · 2019 · DOI 10.21203/rs.2.17404/v1

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Samsung Medical Center trials

Trials by the same sponsor.

NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02843828 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
Last refreshed: 10 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02843828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing